Shanghai Epiprobe Biotechnology Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Shanghai Epiprobe Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Performance Evaluation of a Urine-based Methylation Assay for Urothelial Carcinoma (NCT06912672) | Shanghai Epiprobe Biotechnology Co., Ltd. | 2025-05-01 |
Track Shanghai Epiprobe Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.